PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 29 filers reported holding PHARVARIS N V in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $116 | -100.0% | 10,286 | -90.7% | 0.00% | -100.0% |
| Q3 2022 | $889,000 | -50.9% | 110,666 | +35.0% | 0.00% | 0.0% |
| Q2 2022 | $1,811,000 | -10.7% | 81,954 | -24.4% | 0.00% | 0.0% |
| Q1 2022 | $2,027,000 | +7.2% | 108,386 | -9.3% | 0.00% | 0.0% |
| Q4 2021 | $1,891,000 | -30.5% | 119,558 | -24.2% | 0.00% | -50.0% |
| Q3 2021 | $2,721,000 | -24.0% | 157,753 | -19.9% | 0.00% | 0.0% |
| Q2 2021 | $3,579,000 | -44.8% | 196,967 | -14.7% | 0.00% | -60.0% |
| Q1 2021 | $6,479,000 | – | 230,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,261,926 | $60,770,000 | 8.21% |
| venBio Partners LLC | 2,303,310 | $42,911,000 | 5.06% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $59,255,000 | 3.88% |
| Foresite Capital Management V, LLC | 364,142 | $6,784,000 | 2.67% |
| VR Adviser, LLC | 902,882 | $16,821,000 | 2.04% |
| Cormorant Asset Management, LP | 744,863 | $13,634,000 | 0.46% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,032,757 | $19,240,000 | 0.34% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $45,087,000 | 0.32% |
| Opaleye Management Inc. | 79,837 | $1,487,000 | 0.25% |
| Avidity Partners Management LP | 400,000 | $7,452,000 | 0.20% |